EP2780003
MEÐHÖNDLUN VIÐ NÝRNAHETTUBILUN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.11.2012EP published:
19.2.2020EP application number:
12806617.2
EP translation filed:
16.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
18.11.2032Expiry date:
18.11.2026Next due date:
30.11.2026
Title:
TREATMENT OF ADRENAL INSUFFICIENCY
Timeline
Today
19.11.2012EP application
19.2.2020EP Publication
16.3.2020Translation submitted
15.4.2020Registration published
18.11.2026Expires
Owner
Name:
Neurocrine UK LimitedAddress:
Cardiff MediCentre, Heath ParkCardiffCF14 4UJ, GB
Inventor
Name:
HUATAN, HiepAddress:
Cardiff CF14 4UJ, GB
Name:
ROSS, RichardAddress:
Cardiff CF14 4UJ, GB
Name:
WHITAKER, MartinAddress:
Cardiff CF14 4UJ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201119985Date:
19.11.2011Country:
GB
Classification
Categories:
A61K 9/50, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 27.10.2020
Expires: 18.11.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.10.2021
Expires: 18.11.2022
Payer: The International Renewals Group Inc.
Number: 11
Paid: 25.10.2022
Expires: 18.11.2023
Payer: The International Renewals Group Inc.
Number: 12
Paid: 7.11.2023
Expires: 18.11.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 31.10.2024
Expires: 18.11.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.11.2025
Expires: 18.11.2026
Payer: Árnason Faktor ehf.